Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 11, 2026 8-K
8-K Jan 30, 2026 FORM 8-K
8-K Jan 5, 2026 8-K
4 Dec 23, 2025
4 Nov 19, 2025
10-Q Nov 13, 2025 10-Q
8-K Nov 13, 2025 8-K
8-K Nov 3, 2025 8-K
8-K Oct 17, 2025 8-K
4 Sep 4, 2025
4 Sep 4, 2025
4 Sep 4, 2025
4 Sep 4, 2025
4 Sep 4, 2025
4 Sep 4, 2025
4 Sep 4, 2025
4 Sep 4, 2025
4 Sep 4, 2025
3 Aug 25, 2025
EFFECT Aug 22, 2025
8-K Aug 22, 2025 FORM 8-K
424B5 Aug 22, 2025 424B5
CORRESP Aug 20, 2025
S-3/A Aug 14, 2025 S-3/A
10-Q Aug 14, 2025 10-Q
← Newer Page 2 of 38 · 935 filings Older →